Michael Stoker 1918–2013  by Weiss, Robin A. & Gherardi, Ermanno
Leading Edge
ObituaryMichael Stoker
1918–2013Michael StokerSir Michael Stoker, a pioneer of virology
and the cell biology of cancer cells, died
on 13 August at the age of 95. Viruses
have always been useful tools for probing
the workings of cells, and Michael ex-
ploited tumor-causing viruses to gain a
better understanding of oncogenic mech-
anisms at the dawn of the molecular
biology of animal cells. During a long
career, Michael not only made ground-
breaking discoveries himself, such as
immortal nontransformed cell lines and
scatter factor, but he also had an extraor-
dinary influence on generations of cell
biologists.
Michael George Parke Stoker was born
on 4 July, 1918 in Taunton, England,
where his Irish-born father was a physi-
cian. After school at Oakham, he studied
medicine at Cambridge and gained clin-
ical training at St Thomas’s Hospital at
the beginning of World War II. He then
enlisted in the Royal Army Medical Corps
and was posted to India working in Luck-
now and Hyderabad until, by a stroke of
luck, he was sent to the army laboratories
in Pune, a major military cantonment
(called Poona in colonial times and that
today houses India’s National Institute of
Virology and National AIDS Research
Institute). Michael gained his first experi-
ence of laboratory pathology research in
Pune studying typhus and bush typhus
with some remarkably talented medical
scientists. They included Douglas Black
(later President of the Royal College of
Physicians) and Bill Hayes (who discov-
ered bacterial conjugation and recombi-
nation). It was this experience that gave
Michael his interest in infectious disease
and led him into virology, for the typhus
Rickettsia had not yet been distinguished
from viruses. His research on typhus
provided the material for his MD research
thesis. On demobilization in 1947,
Michael was appointed to a junior post
in the Pathology Department in Cam-
bridge and a fellowship at Clare College.
Together with Peter Wildy, he began to
study herpes simplex virus and exploited
the then novel cell culture techniques
that allowed human and animal virusesto propagate in vitro. Whereas the Pathol-
ogy Department was rather old fashioned,
Michael sought out the new electron
microscope at the Cavendish Physics
Laboratories to visualize virus particles,
and he thus became friends with Max
Perutz, John Kendrew, and the young
Jim Watson.
It was his success in Cambridge that
led him to be appointed without his actu-
ally applying for the position to the first UK
Chair in Virology at the University of Glas-
gow. The University planned to establish
an Institute of Virology, including a Medi-
cal Research Council Unit of Virology
with Michael as Director. Before moving
there, however, Michael spent 6 months
at the end of 1958 at Caltech with Renato
Dulbecco, who was becoming interested
in tumor viruses and in whose laboratory
Howard Temin and Harry Rubin had just
succeeded in developing an in vitro cell
transformation assay for Rous sarcoma
virus. Polyoma virus of mice had recently
been discovered, and with the related
simian virus SV40, it became a model for
neoplastic transformation. In Glasgow,
one particularly important contribution
by Michael, together with Ian Macpher-
son, was the development in 1962 of
BHK21 hamster kidney cell line, anCell 155immortal, easily clonable cell line that
nevertheless maintained growth control
in culture as a monolayer but could
be morphologically transformed by DNA
tumor viruses. Later, murine 3T3 cells
served a similar purpose, but BHK21
was the first cell line with these properties
to be characterized, decades before
the discovery of telomerase and the
mechanisms of immortalization. Working
with BHK21 and derivatives, Michael
described density-dependent inhibition
of growth by normal cells and neighbor
suppression of tumor growth, namely the
ability of normal cells to suppress the
growth of a number of transformed cells
when grown in close contact.
Michael regarded his 9 years in Glas-
gow as the most fruitful of his career.
He brought Peter Wildy with him from
Cambridge, and he recruited key young
investigators such as Lionel Crawford,
Ian Macpherson, Kenny Fraser, John
Subak-Sharpe, and later Mike Fried to
the Institute. In the Glasgow Veterinary
School, Bill Jarrett and collaborators ac-
quired the Institute’s cell biology tech-
niques and discovered feline leukemia
virus and bovine papilloma virus as
models for studying naturally occurring
animal cancers. Thus, Glasgow became
a vibrant center for viral oncology.
Michael established the famous intensive
virology course along the lines of Cold
Spring Harbor Laboratory courses, and
there is hardly a virologist in the UK during
the 1960s and 1970s who did not pass
through the Glasgow Virology Institute.
In 1968, Michael was invited to be
Director of Research at the Imperial Can-
cer Research Fund (ICRF) Laboratories in
London (now part of Cancer Research
UK). He arrived with some key colleagues
fromGlasgow and appointed new cell and
molecular biologists based on a model
similar to the one he established at
the Virology Institute—namely to provide
excellent facilities and give the investiga-
tors free reign without a hierarchy but to
promote lots of interchange and common
internal seminars. There was plenty of
healthy competition, but the ICRF pros-
pered intellectually; among many impor-
tant advances at ICRF, David Lane and
Lionel Crawford discovered that SV40 T
antigen interacted with an unknown
cellular protein called p53 on account of
its molecular weight., October 24, 2013 ª2013 Elsevier Inc. 493
Although Michael was adept at running
sizeable research institutes and setting
their direction of travel, he never devel-
oped a large laboratory himself. He was
content to train one or two research stu-
dents and postdoctoral fellows at a time.
Thanks to his gift for devolving responsi-
bilities and trusting others to expedite
day-to-day management duties, he was
able to find time to conduct his own exper-
imental work. At ICRF, he allowed two
redoubtable colleagues tomeet the needs
of the ambitious and sometimes unruly
scientists among his staff. They were Bill
House, brought from Glasgow to oversee
all the management aspects of keeping
laboratories safe, active, and up to date,
and John Tooze (later Executive Secretary
of the European Molecular Biology Orga-
nization, EMBO), who helped to make
research policies coherent, drafted su-
perb reports and who acted as a talent
scout.
Although Michael had a modest
demeanor, he was held in much esteem
by junior and senior colleagues alike.
Future Nobel laureates such as Paul
Berg and Harold Varmus came on sab-
baticals. Michael recruited three remark-
able senior figures to join him at ICRF.
Renato Dulbecco spent a 5 year sojourn
in London (1972–1977) before returning
to the Salk Institute in La Jolla, and it
was during this time that he was awarded
the Nobel Prize for Physiology or Medi-
cine. John Cairns, Jim Watson’s prede-
cessor as Director of Cold Spring Harbor494 Cell 155, October 24, 2013 ª2013 ElseviLaboratory, came to direct the ICRF Mill
Hill laboratories, where he made pene-
trating observations on the epidemiology
of human cancer from the perspective
of a molecular geneticist. Guido Pon-
tecorvo, universally called Ponte, had
been the founding Professor of Genetics
at the University of Glasgow and was a
world authority on the genetics of the fun-
gus Aspergillus. On moving to the ICRF at
the age of 60, he ran a tiny lab but acted as
an uncle to all; he switched to mammalian
cell genetics and, through his discovery of
cell fusion mediated by polyethylene gly-
col, Ponte greatly expanded somatic cell
genetics and its medical applications,
including the generation of hybrid mye-
lomas producing monoclonal antibodies.
Michael heeded the fruitfulness of
Ponte’s late flowering and, when he him-
self retired as Director of ICRF at 60 and
returned to Cambridge to run a small
lab, his observations on the attachment
and migration of epithelial cells in mono-
layer culture led him to discover ‘‘scatter
factor.’’ He noted that some strains of
fibroblasts induced epithelial cells to
separate from their neighbors instead of
remaining in a tight pavement. This led
to the isolation of a protein, independently
found in Japan to be hepatocyte growth
factor, which plays a fundamental role in
embryo development, organ regenera-
tion, and cancer spreading.
This kind of patient, observational
research, combined with a powerful
analytical mind, characterized Michael’ser Inc.brilliance. Nowadays, big labs and multi-
disciplinary collaborations have become
the favored way of conducting research
and indeed have reaped rich rewards. Yet
Michael and Ponte exemplified the power
of small science leading to big insights—
an approach that today’s biomedical
research funders would do well to ponder.
Michael was knighted in 1980. He was
elected a Fellow of the Royal Society in
1968, and he served as Foreign Secretary
and Vice President 1978 to 1983, a busy
voluntary post that Sydney Brenner
dubbed a travel agency. After returning
to Cambridge, from 1980 to 1987, he
became President of Clare Hall, a newly
established graduate college of the
University. He served on the Council
of EMBO and on several other interna-
tional advisory bodies. Although Michael
thoroughly immersed himself in medical
research, he had broad interests and
hobbies. He enjoyed sailing and became
an accomplished painter, to his own sur-
prise winning the Baron ver Heyden de
Lancey Prize of the Medical Art Society.
The mainstay of Michael’s even
temperament and contentment was his
wife, Veronica, whom he first met as a
student in Cambridge and with whom he
enjoyed a happy marriage for 62 years.
They frequently welcomed colleagues
and friends to their home. Sadly, Veronica
predeceased Michael by 9 years. They
are survived by their five children,
seven grandchildren, and three great
grandchildren.Robin A. Weiss1,* and
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